Recent advances in the management of chronic stable angina I: approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities
- PMID: 20730020
- PMCID: PMC2922325
- DOI: 10.2147/vhrm.s7564
Recent advances in the management of chronic stable angina I: approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities
Abstract
The potential importance of both prevention and personal responsibility in controlling heart disease, the leading cause of death in the USA and elsewhere, has attracted renewed attention. Coronary artery disease is preventable, using relatively simple and inexpensive lifestyle changes. The inexorable rise in the prevalence of obesity, diabetes, dyslipidemia, and hypertension, often in the risk cluster known as the metabolic syndrome, drives the ever-increasing incidence of heart disease. Population-wide improvements in personal health habits appear to be a fundamental, evidence based public health measure, yet numerous barriers prevent implementation. A common symptom in patients with coronary artery disease, classical angina refers to the typical chest pressure or discomfort that results when myocardial oxygen demand rises and coronary blood flow is reduced by fixed, atherosclerotic, obstructive lesions. Different forms of angina and diagnosis, with a short description of the significance of pain and silent ischemia, are discussed in this review. The well accepted concept of myocardial oxygen imbalance in the genesis of angina is presented with new data about clinical pathology of stable angina and acute coronary syndromes. The roles of stress electrocardiography and stress myocardial perfusion scintigraphic imaging are reviewed, along with the information these tests provide about risk and prognosis. Finally, the current status of gender disparities in heart disease is summarized. Enhanced risk stratification and identification of patients in whom procedures will meaningfully change management is an ongoing quest. Current guidelines emphasize efficient triage of patients with suspected coronary artery disease. Many experts believe the predictive value of current decision protocols for coronary artery disease still needs improvement in order to optimize outcomes, yet avoid unnecessary coronary angiograms and radiation exposure. Coronary angiography remains the gold standard in the diagnosis of coronary artery obstructive disease. Part II of this two part series will address anti-ischemic therapies, new agents, cardiovascular risk reduction, options to treat refractory angina, and revascularization.
Keywords: acute coronary syndrome; angina; cardiovascular risk assessment; coronary angiography; coronary artery disease; electrocardiographic stress testing; gender disparities in heart disease; ischemic heart disease; myocardial oxygen balance; silent ischemia; stress myocardial perfusion imaging.
Figures

Similar articles
-
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.Vasc Health Risk Manag. 2010 Sep 7;6:749-74. doi: 10.2147/vhrm.s11100. Vasc Health Risk Manag. 2010. PMID: 20859545 Free PMC article. Review.
-
Nonacute coronary syndrome anginal chest pain.Med Clin North Am. 2010 Mar;94(2):201-16. doi: 10.1016/j.mcna.2010.01.008. Med Clin North Am. 2010. PMID: 20380951 Free PMC article. Review.
-
API expert consensus document on management of ischemic heart disease.J Assoc Physicians India. 2006 Jun;54:469-80. J Assoc Physicians India. 2006. PMID: 16909697 Review.
-
Excluding heart disease in the patient with chest pain.Am J Med. 1992 May 27;92(5A):46S-51S. doi: 10.1016/0002-9343(92)80056-6. Am J Med. 1992. PMID: 1595764 Review.
-
The pathophysiology of chronic ischemic heart disease.Clin Cardiol. 2007 Feb;30(2 Suppl 1):I4-9. doi: 10.1002/clc.20048. Clin Cardiol. 2007. PMID: 18373328 Free PMC article. Review.
Cited by
-
Circulating miR-214 is associated with the severity of coronary artery disease.J Geriatr Cardiol. 2013 Mar;10(1):34-8. doi: 10.3969/j.issn.1671-5411.2013.01.007. J Geriatr Cardiol. 2013. PMID: 23610572 Free PMC article.
-
Pharmacological treatment of chronic stable angina pectoris.Clin Med (Lond). 2013 Feb;13(1):63-70. doi: 10.7861/clinmedicine.13-1-63. Clin Med (Lond). 2013. PMID: 23472498 Free PMC article. Review.
-
The emerging role of medical foods and therapeutic potential of medical food-derived exosomes.Nanoscale Adv. 2023 Nov 11;6(1):32-50. doi: 10.1039/d3na00649b. eCollection 2023 Dec 19. Nanoscale Adv. 2023. PMID: 38125597 Free PMC article. Review.
-
Quality of the Evidence Supporting the Role of Acupuncture for Stable Angina Pectoris: An Umbrella Review of Systematic Reviews.Front Cardiovasc Med. 2021 Sep 30;8:732144. doi: 10.3389/fcvm.2021.732144. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34660732 Free PMC article.
-
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective.Drug Des Devel Ther. 2010 Dec 9;4:383-413. doi: 10.2147/DDDT.S10812. Drug Des Devel Ther. 2010. PMID: 21267417 Free PMC article. Review.
References
-
- Skalski JH. Myocardial infarction and angina pectoris in the history of Polish medicine. Pol Arch Med Wewn. 2008;118(4):243–247. - PubMed
-
- Iqbal J, Fox KAA. Epidemiological trends in acute coronary syndromes: understanding the past to predict and improve the future. Arch Med Sci. 2010;6(1A):S3–S14.
-
- Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation. J Am Coll Cardiol. 2006;48:677–685. - PubMed
-
- Ikeda U. Inflammation and coronary artery disease. Curr Vasc Pharmacol. 2003;1(1):65–70. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical